BIT 0.00% 3.3¢ biotron limited

Great development for Biotron. NIAID funding derisks a lot of...

  1. 233 Posts.
    Great development for Biotron. NIAID funding derisks a lot of the preclinical development and showcases the strength of the compound portfolio.

    Let's watch and see how the market responds. Hopefully, the Australian picks this up on its business news and maybe a spot on Sky Business for MM.

    Strong buy at current price in my view.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.3¢
Change
0.000(0.00%)
Mkt cap ! $29.77M
Open High Low Value Volume
3.3¢ 3.5¢ 3.2¢ $8.822K 265.5K

Buyers (Bids)

No. Vol. Price($)
1 45155 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 65500 1
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.